Merus Bv Stock Performance
| MRUS Stock | USD 46.39 0.83 1.76% |
On a scale of 0 to 100, Merus BV holds a performance score of 6. The company secures a Beta (Market Risk) of -0.28, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Merus BV are expected to decrease at a much lower rate. During the bear market, Merus BV is likely to outperform the market. Please check Merus BV's potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to make a quick decision on whether Merus BV's current price movements will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Merus BV are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Merus BV may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
Actual Historical Performance (%)
One Day Return (1.76) | Five Day Return (5.63) | Year To Date Return 9.67 | Ten Year Return 362.05 | All Time Return 362.05 |
1 | Disposition of 1000 shares by Harry Shuman of Merus BV at 18.61 subject to Rule 16b-3 | 12/19/2024 |
2 | Merus NV and Biohaven Announce Strategic Collaboration on Bispecific Antibody Drug Conjugates | 01/13/2025 |
3 | Acquisition by Zohren Fabian of 50000 shares of Merus BV at 41.65 subject to Rule 16b-3 | 01/29/2025 |
4 | Wells Fargo Company Begins Coverage on Merus | 02/07/2025 |
5 | Petosemtamab granted Breakthrough Therapy designation by the U.S. ... | 02/18/2025 |
6 | La FDA amricaine a accord le statut de thrapie innovante au ptosemtamab dans le carcinome pidermode de la tte et du cou positif PD-L1 positif en 1re ligne | 02/19/2025 |
7 | Merus Power Oyj Full Year 2024 Earnings Beats Expectations | 02/20/2025 |
8 | Merus NV Announces Key Developments in Oncology Trials and Financial Results | 02/27/2025 |
9 | Global Zygomatic and Pterygoid Implant Market to Witness Upsurge in Growth at a CAGR of 6 percent by 2032 DelveInsight | 03/06/2025 |
10 | Acquisition by Hui Liu of 98085 shares of Merus BV at 7.86 subject to Rule 16b-3 | 03/13/2025 |
11 | Disposition of 1000 shares by Harry Shuman of Merus BV at 24.43 subject to Rule 16b-3 | 03/14/2025 |
| Begin Period Cash Flow | 205 M |
Merus |
Merus BV Relative Risk vs. Return Landscape
If you would invest 4,209 in Merus BV on December 19, 2024 and sell it today you would earn a total of 430.00 from holding Merus BV or generate 10.22% return on investment over 90 days. Merus BV is currently generating 0.1961% in daily expected returns and assumes 2.5129% risk (volatility on return distribution) over the 90 days horizon. In different words, 22% of stocks are less volatile than Merus, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Merus BV Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Merus BV's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Merus BV, and traders can use it to determine the average amount a Merus BV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.078
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MRUS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.51 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.2 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Merus BV is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Merus BV by adding it to a well-diversified portfolio.
Merus BV Fundamentals Growth
Merus Stock prices reflect investors' perceptions of the future prospects and financial health of Merus BV, and Merus BV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Merus Stock performance.
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.27 | ||||
| Operating Margin | (9.70) % | ||||
| Current Valuation | 2.74 B | ||||
| Shares Outstanding | 69.09 M | ||||
| Price To Earning | (4.47) X | ||||
| Price To Book | 5.04 X | ||||
| Price To Sales | 90.29 X | ||||
| Revenue | 36.13 M | ||||
| Gross Profit | 13.42 M | ||||
| EBITDA | (269.6 M) | ||||
| Net Income | (215.33 M) | ||||
| Cash And Equivalents | 376.11 M | ||||
| Cash Per Share | 8.20 X | ||||
| Total Debt | 9.91 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 6.62 X | ||||
| Book Value Per Share | 9.41 X | ||||
| Cash Flow From Operations | (185.84 M) | ||||
| Earnings Per Share | (3.35) X | ||||
| Market Capitalization | 3.26 B | ||||
| Total Asset | 782.69 M | ||||
| Retained Earnings | (968.39 M) | ||||
| Working Capital | 482 M | ||||
| Current Asset | 68 M | ||||
| Current Liabilities | 5 M | ||||
About Merus BV Performance
Assessing Merus BV's fundamental ratios provides investors with valuable insights into Merus BV's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Merus BV is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 326.22 | 342.53 | |
| Return On Tangible Assets | (0.28) | (0.29) | |
| Return On Capital Employed | (0.36) | (0.34) | |
| Return On Assets | (0.28) | (0.29) | |
| Return On Equity | (1.07) | (1.02) |
Things to note about Merus BV performance evaluation
Checking the ongoing alerts about Merus BV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Merus BV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 36.13 M. Net Loss for the year was (215.33 M) with profit before overhead, payroll, taxes, and interest of 13.42 M. | |
| Merus BV currently holds about 376.11 M in cash with (185.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.2. | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of 1000 shares by Harry Shuman of Merus BV at 24.43 subject to Rule 16b-3 |
- Analyzing Merus BV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Merus BV's stock is overvalued or undervalued compared to its peers.
- Examining Merus BV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Merus BV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Merus BV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Merus BV's stock. These opinions can provide insight into Merus BV's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Merus Stock Analysis
When running Merus BV's price analysis, check to measure Merus BV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merus BV is operating at the current time. Most of Merus BV's value examination focuses on studying past and present price action to predict the probability of Merus BV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merus BV's price. Additionally, you may evaluate how the addition of Merus BV to your portfolios can decrease your overall portfolio volatility.